BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Sponsor
Bayer (Industry)
Overall Status
Completed
CT.gov ID
NCT00099502
Collaborator
(none)
2,244
199
3
45
11.3
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine

  • whether treatment with Betaferon / Betaseron (interferon beta-1b) 500 micrograms safe, tolerable and more efficacious than treatment with interferon beta-1b 250 micrograms

  • whether treatment with Betaferon / Betaseron (interferon beta-1b) tolerable and more efficacious than treatment with Copaxone (Glatiramer Acetate) 20 mg

Condition or Disease Intervention/Treatment Phase
  • Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
  • Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
  • Drug: Copaxone
Phase 3

Detailed Description

This study has previously been posted by Berlex, Inc. and Schering AG, Germany. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc., Schering AG Germany has been renamed to Bayer Schering Pharma AG, Germany.

Bayer HealthCare Pharmaceuticals, Inc.and Bayer Schering Pharma AG, Germany are the sponsors of the trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
2244 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
International, Randomized, Multicenter, Phase IIIb Study in Patients With Relapsing-Remitting Multiple Sclerosis Comparing Over a Treatment Period of at Least 104 Weeks: 1. Double-Blinded Safety, Tolerability, and Efficacy of Betaseron/ Betaferon 250 µg (8 MIU) and Betaseron/-Betaferon 500 µg (16 MIU), Both Given Subcutaneously Every Other Day, and 2. Rater-Blinded Safety, Tolerability, and Efficacy of Betaseron/-Betaferon s.c. Every Other Day With Copaxone 20 mg s.c. Once Daily.
Study Start Date :
Nov 1, 2003
Actual Study Completion Date :
Aug 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1

Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
250mcg administered s.c. every other day

Experimental: Arm 2

Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
500mcg administered s.c. every other day

Active Comparator: Arm 3

Drug: Copaxone
20 mg administered s.c. once daily.

Outcome Measures

Primary Outcome Measures

  1. Hazard ratio for relapses [During the first and during the second 52 weeks]

Secondary Outcome Measures

  1. Time to confirmed Expanded Disability Status Score (EDSS) progression [After 52 and after 104 weeks]

  2. Magnetic Resonance Imaging (MRI): Change from screening in volume of hypointense lesion on enhanced T1 weighted images [After 104 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female and male patients

  • Aged 18-55 years

  • Diagnosis of RRMS (Relapsing-Remitting Multiple Sclerosis), EDSS score of 0 to 5.0

  • Treatment-naive to IFNB or Copaxone

Exclusion Criteria:
  • Neurological progression at disease onset or between relapses

  • Serious or acute heart diseases

  • History of severe depression or suicide attempt

  • Serious or acute liver, renal or bone marrow dysfunction

  • Monoclonal gammopathy

  • Known allergy to Gadolinium-DTPA, to IFNs (Interferons), to glatiramer acetate, to human albumin or to mannitol

  • Pregnancy or lactation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Birmingham Alabama United States 35294
2 Cullman Alabama United States 35058
3 Phoenix Arizona United States 85013
4 Tucson Arizona United States 85741-3537
5 Berkeley California United States 94705
6 La Jolla California United States 92037
7 Sacramento California United States 95817
8 San Francisco California United States 94117
9 Englewood Colorado United States 80110
10 Fort Collins Colorado United States 80528
11 Wilmington Delaware United States 19806
12 Washington District of Columbia United States 20037
13 Miami Florida United States 33125
14 Tampa Florida United States 33606-3508
15 Tampa Florida United States 33609
16 Atlanta Georgia United States 30309-1465
17 Augusta Georgia United States 30912
18 Chicago Illinois United States 60637-1470
19 Fort Wayne Indiana United States 46805
20 Indianapolis Indiana United States 46202
21 Des Moines Iowa United States 50314
22 Kansas City Kansas United States 66160
23 Lexington Kentucky United States 40536
24 Louisville Kentucky United States 40202
25 Shreveport Louisiana United States 71130
26 Detroit Michigan United States 48202
27 Duluth Minnesota United States 55805-1984
28 St. Louis Missouri United States 63110
29 Henderson Nevada United States 89052
30 Reno Nevada United States 89557-0035
31 Lebanon New Hampshire United States 03756-0001
32 New Brunswick New Jersey United States 08901
33 Albuquerque New Mexico United States 87131
34 Albany New York United States 12208
35 Mineola New York United States 11501-3987
36 Rochester New York United States 14642
37 Stony Brook New York United States 11794
38 Charlotte North Carolina United States 28203
39 Durham North Carolina United States 27710
40 High Point North Carolina United States 27262
41 Winston-Salem North Carolina United States 27157-1009
42 Cincinnati Ohio United States 45219
43 Columbus Ohio United States 43210-1240
44 Tualatin Oregon United States 97062
45 Philadelphia Pennsylvania United States 19104
46 Philadelphia Pennsylvania United States 19107
47 Pittsburgh Pennsylvania United States 15213-2592
48 Providence Rhode Island United States 02905
49 Charleston South Carolina United States 29425
50 Nashville Tennessee United States 37205
51 Houston Texas United States 77030
52 San Antonio Texas United States 78229
53 Fairfax Virginia United States 22031
54 Seattle Washington United States 98101
55 Tacoma Washington United States 98405
56 Marshfield Wisconsin United States 54449
57 Milwaukee Wisconsin United States 53215
58 Buenos Aires Capital Federal Argentina C1117ABE
59 Buenos Aires Capital Federal Argentina C1280AEB
60 Rosario Santa Fe Argentina S2000CVB
61 Rosario Santa Fe Argentina S2000ZBL
62 Buenos Aires Argentina C1416CRJ
63 Cordoba Argentina X5000HGX
64 Gosford New South Wales Australia 2250
65 Kogarah New South Wales Australia 2217
66 Liverpool New South Wales Australia 2170
67 Melbourne Victoria Australia 3065
68 Parkville Victoria Australia 3050
69 Nedlands Western Australia Australia 6009
70 St. Pölten Niederösterreich Austria 3100
71 Graz Steiermark Austria 8036
72 Innsbruck Tirol Austria 6020
73 Linz Austria 4020
74 Bruxelles - Brussel Belgium 1090
75 Leuven Belgium 3000
76 Melsbroek Belgium 1820
77 Curitiba Parana Brazil 80060-900
78 Recife PE Brazil 52010-040
79 Rio de Janeiro RJ Brazil 21949 900
80 Porto Alegre RS Brazil
81 Campinas Sao Paulo Brazil 13081- 970
82 Sao Paulo SP Brazil 05403-900
83 Sao Pulo SP Brazil 05651-901
84 Sao Paulo Brazil 04039
85 Calgary Alberta Canada T2N 2T9
86 Vancouver British Columbia Canada V6T 2B5
87 Winnipeg Manitoba Canada R3A 1R9
88 Halifax Nova Scotia Canada B3H 3A7
89 London Ontario Canada N6A 5A5
90 Mississauga Ontario Canada L5B 1B8
91 Nepean Ontario Canada K2G 6E2
92 Ottawa Ontario Canada K1H 8L6
93 Toronto Ontario Canada M5C 2T2
94 Greenfield Park Quebec Canada J4V 2H1
95 Hull Quebec Canada J8Y 1W7
96 Montreal Quebec Canada H2L 4M1
97 Montreal Quebec Canada H3A 2B4
98 Aarhus C Denmark 8000
99 Oulu Finland
100 Tampere Finland 33521
101 Rennes Bretagne France 35038
102 Bordeaux Gironde France 33076
103 Caen France F-14033
104 Clermont ferrand France 63003
105 Dijon France 21033
106 Lille France 59037
107 Lyon France 69003
108 Nancy France 54035
109 Nantes France 44805
110 Nice France 06000
111 Nimes France 30029
112 Toulouse France 31059
113 Heidelberg Baden-Württemberg Germany 69112
114 Bayreuth Bayern Germany 95445
115 Regensburg Bayern Germany 93053
116 Hennigsdorf Brandenburg Germany 16761
117 Gießen Hessen Germany 35392
118 Marburg Hessen Germany 35043
119 Offenbach Hessen Germany 63069
120 Greifswald Mecklenburg-Vorpommern Germany 17489
121 Göttingen Niedersachsen Germany 37075
122 Hannover Niedersachsen Germany 30171
123 Hannover Niedersachsen Germany 30625
124 Düsseldorf Nordrhein-Westfalen Germany 40225
125 Essen Nordrhein-Westfalen Germany 45177
126 Münster Nordrhein-Westfalen Germany 48149
127 Asbach Rheinland-Pfalz Germany 53567
128 Halle Sachsen-Anhalt Germany 06120
129 Dresden Sachsen Germany 01307
130 Leipzig Sachsen Germany 04129
131 Berlin Germany 13347
132 Berlin Germany 13578
133 Hamburg Germany 20099
134 Hamburg Germany 20251
135 Athens Attica Greece 11527
136 Athens Greece 15127
137 Thessaloniki Greece 546 36
138 Budapest Hungary 1076
139 Budapest Hungary 1145
140 Györ Hungary 9024
141 Miskolc Hungary 3526
142 Pecs Hungary 7623
143 Zalaegerszeg Hungary 8900
144 Dublin Dublin 24 Ireland
145 Cork Ireland
146 Dublin Ireland 7
147 Dublin Ireland 9
148 Dublin Ireland DUBLIN 4
149 Ashkelon Israel 78306
150 Haifa Israel 31048
151 Haifa Israel 34362
152 Jerusalem Israel 91120
153 Petach Tikva Israel 49100
154 Tel Hashomer Israel 52621
155 Tel-Aviv Israel 64239
156 Zerifin Israel 70300
157 Bari BA Italy 70122
158 Firenze FI Italy 50134
159 Milano MI Italy 20132
160 Padova PD Italy 35128
161 Roma RO Italy 00189
162 Orbassano TO Italy 10043
163 Riga Latvia LV-1015
164 Nijmegen Gelderland Netherlands 6533 PA
165 Breda Netherlands 4819 EV
166 Sittard Netherlands 6131 BK
167 Bergen Norway N-5021
168 Gdansk Poland 80-803
169 Katowice Poland 40752
170 Lodz Poland 90-153
171 Poznan Poland 60-355
172 Warszawa Poland 02-097
173 Warszawa Poland 02957
174 Wroclaw Poland 50-417
175 Moscow Russian Federation 117049
176 Moscow Russian Federation 119048
177 Moskva Russian Federation 123367
178 Moskva Russian Federation 127018
179 Moskva Russian Federation 129110
180 Nizhny Novogorod Russian Federation 603076
181 Novosibirsk Russian Federation 630007
182 Sankt-Peterburg Russian Federation 194044
183 Sankt-Peterburg Russian Federation 197376
184 St. Petersburg Russian Federation 197022
185 Yaroslavl Russian Federation 150039
186 Ljubljana Slovenia 1000
187 Maribor Slovenia 2000
188 L'Hospitalet de Llobregat Barcelona Spain 08907
189 Málaga Spain 29010
190 Sevilla Spain 41071
191 Helsingborg Sweden 25278
192 Stockholm Sweden 182 88
193 Uppsala Sweden 75185
194 Bern Switzerland 3010
195 St. Gallen Switzerland 9007
196 Donetsk Ukraine 83003
197 Kharkiv Ukraine 61068
198 Kiev Ukraine 03110
199 Lviv Ukraine 79000

Sponsors and Collaborators

  • Bayer

Investigators

  • Study Director: Bayer Study Director, Bayer

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00099502
Other Study ID Numbers:
  • 91162
  • EudraCT: 2005-002235-27
  • 306440
  • Beyond
  • NCT00185432
First Posted:
Dec 16, 2004
Last Update Posted:
Dec 19, 2008
Last Verified:
Dec 1, 2008

Study Results

No Results Posted as of Dec 19, 2008